Cheryl R. Blanchard, Ph.D.

Cheryl R. Blanchard, Ph.D.

Executive Chair; Former President and Chief Executive OfficeratAnika Therapeutics· In proxies 2021–2025

Pay in FY2025-4% from the year before · Anika Therapeutics stock -41.6% the same year

Cheryl R. Blanchard, Ph.D. was paid $4.9M in FY2025 (Dec), down 4%. Anika Therapeutics stock fell 41.6% that year.

Pay$100 in the stock at the end of FY20 → $21
Pay is from the Summary Compensation Table of each Anika Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Anika TherapeuticsPublic company · 5 yr
    • Executive Chair; Former President and Chief Executive Officer2021 – Present · 5 yrStock in role -50%

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?